CRISPR,

Tianying Zhan1, Xiao Li2, Jiumin Liu3,4

  • 1Department of Clinical Laboratory, Guangdong Provincial Key Laboratory of Major Obstetric Diseases; Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology; The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

概括

研究人员开发了一种新的双抗体系统,通过抑制NF-κB和β-catenin来提高CRISPR基因编辑效率. 该系统增强了CRISPR-CasΦ的表达,并显示了瘤治疗和转基因应用的前景.